<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T06:57:55Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2072/456323" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2072/456323</identifier><datestamp>2026-03-26T04:03:11Z</datestamp><setSpec>com_2072_98</setSpec><setSpec>col_2072_378192</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Electronegative LDL Promotes Inflammation and Triglyceride Accumulation in Macrophages</dc:title>
   <dc:creator>Puig Grifol, Núria</dc:creator>
   <dc:creator>Montolio, Lara</dc:creator>
   <dc:creator>Camps-Renom, Pol</dc:creator>
   <dc:creator>Navarra, Laia</dc:creator>
   <dc:creator>Jiménez Altayó, Francesc</dc:creator>
   <dc:creator>Jiménez Xarrié, Elena</dc:creator>
   <dc:creator>Sánchez Quesada, José Luis</dc:creator>
   <dc:creator>Benitez, Sonia</dc:creator>
   <dc:creator>Universitat Autònoma de Barcelona</dc:creator>
   <dc:subject>HDL</dc:subject>
   <dc:subject>TLR4</dc:subject>
   <dc:subject>Electronegative LDL</dc:subject>
   <dc:subject>Foam cells</dc:subject>
   <dc:subject>Inflammation</dc:subject>
   <dc:subject>Lipid droplets</dc:subject>
   <dc:subject>Macrophages</dc:subject>
   <dc:subject>Scavenger receptors</dc:subject>
   <dc:subject>Triglycerides</dc:subject>
   <dc:description>Altres ajuts: This research was funded by grants 158/U/2017 from Fundacio La Marato TV3.</dc:description>
   <dc:description>Electronegative low-density lipoprotein (LDL) (LDL(-)), a modified LDL that is present in blood and exerts atherogenic effects on endothelial cells and monocytes. This study aimed to determine the action of LDL(-) on monocytes differentiated into macrophages. LDL(-) and in vitro-modified LDLs (oxidized, aggregated, and acetylated) were added to macrophages derived from THP1 monocytes over-expressing CD14 (THP1-CD14). Then, cytokine release, cell differentiation, lipid accumulation, and gene expression were measured by ELISA, flow cytometry, thin-layer chromatography, and real-time PCR, respectively. LDL(-) induced more cytokine release in THP1-CD14 macrophages than other modified LDLs. LDL(-) also promoted morphological changes ascribed to differentiated macrophages. The addition of high-density lipoprotein (HDL) and anti-TLR4 counteracted these effects. LDL(-) was highly internalized by macrophages, and it was the major inductor of intracellular lipid accumulation in triglyceride-enriched lipid droplets. In contrast to inflammation, the addition of anti-TLR4 had no effect on lipid accumulation, thus suggesting an uptake pathway alternative to TLR4. In this regard, LDL(-) upregulated the expression of the scavenger receptors CD36 and LOX-1, as well as several genes involved in triglyceride (TG) accumulation. The importance and novelty of the current study is that LDL(-), a physiologically modified LDL, exerted atherogenic effects in macrophages by promoting differentiation, inflammation, and triglyceride-enriched lipid droplets formation in THP1-CD14 macrophages, probably through different receptors.</dc:description>
   <dc:date>2020</dc:date>
   <dc:type>Article</dc:type>
   <dc:identifier>https://ddd.uab.cat/record/241128</dc:identifier>
   <dc:identifier>urn:10.3390/cells9030583</dc:identifier>
   <dc:identifier>urn:oai:ddd.uab.cat:241128</dc:identifier>
   <dc:identifier>urn:articleid:20734409v9n3ecells9030583</dc:identifier>
   <dc:identifier>urn:scopus_id:85089547011</dc:identifier>
   <dc:identifier>urn:pmid:32121518</dc:identifier>
   <dc:identifier>urn:oai:egreta.uab.cat:publications/1aa69dc7-9db0-4b68-b5d2-8ba23cde193a</dc:identifier>
   <dc:identifier>urn:pmc-uid:7140452</dc:identifier>
   <dc:identifier>urn:pmcid:PMC7140452</dc:identifier>
   <dc:identifier>urn:oai:pubmedcentral.nih.gov:7140452</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Instituto de Salud Carlos III PI16-00471</dc:relation>
   <dc:relation>Instituto de Salud Carlos III CB07-08-0016</dc:relation>
   <dc:relation>Instituto de Salud Carlos III RD16-0019-0010</dc:relation>
   <dc:relation>Agència de Gestió d'Ajuts Universitaris i de Recerca 2017/SGR-1149</dc:relation>
   <dc:relation>Cells ; Vol. 9 Núm. 3 (january 2020)</dc:relation>
   <dc:rights>open access</dc:rights>
   <dc:rights>Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.</dc:rights>
   <dc:rights>https://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher/>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>